← back to search

Yunfei Wang

Zhengzhou University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Circular RNAs in diseases, and RNA Research and Splicing.
h-index
42
citations
6,432
works
238
NIH funding
primary concept
email

Recent publications

NEU1 sustains mitochondria-lysosome contacts to trigger lysosomal Cu2+/cathepsin escape and mitochondrial lysis in glioblastoma (NeuLysis)
Neuro-Oncology 2026cited by 0position: contributordoi
circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4
Molecular Cancer 2025cited by 35position: firstdoi
How growing up without siblings affects the adult brain and behaviour in the CHIMGEN cohort
Nature Human Behaviour 2025cited by 5position: middledoi
Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma
Acta Pharmaceutica Sinica B 2025cited by 3position: contributordoi
Predictive Value of Residual SYNTAX Score II for Patients With Complex Coronary Disease and Chronic Renal Insufficiency After Percutaneous Coronary Intervention
Reviews in Cardiovascular Medicine 2025cited by 0position: middledoi
mPPTMP195 nanoparticles enhance fracture recovery through HDAC4 nuclear translocation inhibition
Journal of Nanobiotechnology 2024cited by 2position: middledoi
Comparison of Fractional Flow Reserve and Resting Full-Cycle Ratio in the Functional Assessment of Coronary Artery Stenosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
Reviews in Cardiovascular Medicine 2024cited by 0position: middledoi
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
Cancer Communications 2023cited by 48position: middledoi
Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
Bone and Joint Research 2023cited by 8position: middledoi
Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A.
2022cited by 66position: contributordoi
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
Theranostics 2022cited by 38position: middledoi
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.
2022cited by 29position: contributordoi
The Level of Histone Deacetylase 4 is Associated with Aging Cartilage Degeneration and Chondrocyte Hypertrophy
Journal of Inflammation Research 2022cited by 18position: middledoi
Inactivation of Ihh in Sp7-Expressing Cells Inhibits Osteoblast Proliferation, Differentiation, and Bone Formation, Resulting in a Dwarfism Phenotype with Severe Skeletal Dysplasia in Mice
Calcified Tissue International 2022cited by 16position: firstdoi
The guiding value of hybrid resting full-cycle ratio and fractional flow reserve strategy for percutaneous coronary intervention in a Chinese real-world cohort with non-ST elevation acute coronary syndrome
Frontiers in Cardiovascular Medicine 2022cited by 4position: middledoi
1462 Adrenergic signaling augments cytotoxic T cell anti tumor activity in p53 deficient cancers by CXCL10 release
Regular and Young Investigator Award Abstracts 2022cited by 0position: middledoi
HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas
Frontiers in Immunology 2021cited by 36position: firstdoi
Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage
Frontiers in Oncology 2021cited by 35position: middledoi
HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas.
2021cited by 31position: contributordoi
Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke.
2021cited by 21position: contributordoi
Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.
2021cited by 11position: contributordoi
Sequence variant analysis reveals poor correlations in microbial taxonomic abundance between humans and mice after gnotobiotic transfer
The ISME Journal 2020cited by 50position: middledoi
EGFR‐vIII downregulated H2AZK4/7AC though the PI3K/AKT‐HDAC2 axis to regulate cell cycle progression
Clinical and Translational Medicine 2020cited by 25position: middledoi
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep
Theranostics 2019cited by 97position: middledoi
Long non-coding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer.
2019cited by 91position: contributordoi
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.
2019cited by 79position: contributordoi
Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2
Clinical Epigenetics 2019cited by 79position: contributordoi
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
Advanced Science 2019cited by 71position: contributordoi
NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment
Nano Letters 2019cited by 64position: middledoi
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
2019cited by 58position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Chunsheng Kang · Tianjin Medical University General Hospital10 papers (2017–2023)Yanli Tan · Tobacco Research Institute7 papers (2018–2023)Qixue Wang · Ministry of Education of the People's Republic of China7 papers (2017–2023)Junhu Zhou · Dartmouth College7 papers (2017–2023) · 5 papers (2018–2023)Chao Yang · Ningbo University4 papers (2018–2023)Chunsheng Kang · Tianjin Medical University General Hospital4 papers (2019–2026)Jinquan Cai · Harbin Medical University4 papers (2017–2019)Xufen Cao · Hebei Medical University4 papers (2018–2025)Yansheng Li · Chongqing University of Posts and Telecommunications3 papers (2018–2021)Liqiu Yan · Guangxi Medical University3 papers (2018–2024) · 3 papers (2018–2023) · 3 papers (2019–2026) · 3 papers (2021–2023)Xiaochun Wei · University of Georgia3 papers (2022–2023)Shuaiyong Zhang · Shandong University3 papers (2022–2025)Yumeng Lei · Guangdong Medical College3 papers (2022–2025) · 3 papers (2019–2022)Ming Chen · Shandong Academy of Chinese Medicine2 papers (2022–2024)Mingyang Liu · Chinese Academy of Tropical Agricultural Sciences2 papers (2017–2019)